Skip to main content
Log in

Kutaner maligner peripherer Nervenscheidentumor bei Neurofibromatose Typ 1

Cutaneous malignant peripheral nerve sheath tumor in neurofibromatosis type 1

  • Kasuistiken
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Patienten mit Neurofibromatose haben ein gegenüber der Normalbevölkerung erhöhtes Risiko, Malignome zu entwickeln. Wir berichten über eine Patientin, bei der sich ein maligner peripherer Nervenscheidentumor aus einem präexistenten Neurofibrom entwickelte.

Abstract

Patients with neurofibromatosis have an increased risk of developing malignant tumors in comparison to the general population. We describe a woman who developed a malignant peripheral nerve sheath tumor in a pre-existing neurofibroma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Coindre JM, Terrier Ph, Guillou L et al (2001) Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas. A study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 91:1914–1926

    Article  PubMed  CAS  Google Scholar 

  2. Cox A (2001) Farnesyltransferase inhibitors: potential role in the treatment of cancer. Drugs 61:723–732

    Article  PubMed  CAS  Google Scholar 

  3. Ducatman B, Scheithauer B, Piepgras D et al (1986) Malignant peripheral nerve sheath tumors: a clinicopathologic study of 120 cases. Cancer 57:2006–2021

    Article  PubMed  CAS  Google Scholar 

  4. Enziger FM, Weiss SW (2001) Benign tumors of peripheral nerves: malignant tumors of the peripheral nerves. In: Weiss SW, Goldblum JR (eds) Soft tissue tumors, 4th edn, Mosby, St. Louis, MO, pp 1111–1263

  5. Ferner RE, Lucas JD, O Doherty MJ et al (2000) Evaluation of 18 fluorodeoxyglucose positron emission tomography in the detection of malignant peripheral nerve sheath tumors in neurofibromatosis. J Neurol Neurosurg Psychiatry 68:353–357

    Article  PubMed  CAS  Google Scholar 

  6. Ferner R, Gutmann D (2002) International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1. Cancer Res 62:1573–1577

    PubMed  CAS  Google Scholar 

  7. Ferner RE (2007) Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 4:340–351

    Article  Google Scholar 

  8. George E, Swanson P, Wick M (1989) Malignant peripheral nerve sheath tumors of the skin. Am J Dermatopathol 11:213–221

    Article  PubMed  CAS  Google Scholar 

  9. Santoro A, Tursz T, Mouridsen H et al (1995) Doxorubicin versus CY VADIC versus doxorubicin plus ifosfamide in the first-line treatment of advanced soft tissue sarcomas: a randomized study of the EORTC Soft Tissue und Bone Sarcoma Group. J Clin Oncol 13:1537–1545

    PubMed  CAS  Google Scholar 

  10. Wojtkowiak JW, Fouad F, Lalonde DT et al (2008) Induction of apoptosis in Neurofibromatosis Typ 1 malignant peripheral nerve shath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. J Pharmacol Exp Ther (epub ahead of print)

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Dietrich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dietrich, V., Schaller, J. & Kunze, J. Kutaner maligner peripherer Nervenscheidentumor bei Neurofibromatose Typ 1. Hautarzt 60, 830–833 (2009). https://doi.org/10.1007/s00105-008-1700-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-008-1700-2

Schlüsselwörter

Keywords

Navigation